NEW YORK (GenomeWeb) – The Korean Ministry of Food and Drug Safety has cleared NGeneBio's BRCAaccuTest for clinical use. The Seoul-based company said this week that its next-generation sequencing panel has been approved as an IVD, the first NGS test to be cleared in Korea.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.